Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 COH parameters and ART outcomes. Mean values are reported, with standard deviation in brackets; statistical significance for p < 0.05; ns = not significant

From: A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Entry

Group A n = 150

Group B n = 150

p-value

Gonadotropins (IU)

2526 (974.4)

1647 (756)

< 0.05

Oocytes retrieved (COCs)

5.9 (2.1)

5.48 (2.21)

ns

Metaphase II oocytes

4.81 (1.38)

4.48 (1.87)

ns

2PN oocytes fertilized

3.85 (1.1)

3.59 (1.5)

ns

Top quality embryos/blastocysts transferred

1.52 (0.54)

1.47 (0.53)

ns

Back to article page

Health Economics Review

ISSN: 2191-1991

Contact us